Polar Capital Holdings PLC Adicet Bio, Inc. Transaction History

Polar Capital Holdings PLC

  • $16.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Dec 13, 2023
BUY
$5.52 - $9.23 $6.98 Million - $11.7 Million
1,263,825 New
1,263,825 $7.28 Million
Q4 2022

Feb 14, 2023
SELL
$7.72 - $21.27 $230,403 - $634,803
-29,845 Reduced 2.31%
1,263,825 $11.3 Million
Q3 2022

Nov 14, 2022
SELL
$13.43 - $18.74 $3.36 Million - $4.69 Million
-250,000 Reduced 16.2%
1,293,670 $18.4 Million
Q1 2022

May 16, 2022
BUY
$11.53 - $19.97 $189,057 - $327,448
16,397 Added 1.07%
1,543,670 $30.8 Million
Q4 2021

Feb 14, 2022
BUY
$7.37 - $17.49 $11.3 Million - $26.7 Million
1,527,273 New
1,527,273 $26.7 Million

Others Institutions Holding ACET

# of Institutions
72
Shares Held
59.2M
Call Options Held
4.2K
Put Options Held
6.7K
View Full List

About Adicet Bio, Inc.

ACET Quotes by TradingView
  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $36M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email